To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

October 22, 2015

ChrisElliottFund Officially Re-launched as The EndBrainCancer Initiative

The Chris Elliott Fund has officially re-launched in 2015 as the EndBrainCancer Initiative. Historically, our 501 (c)3 non-profit corporation has been associated with Christopher Stewart Elliott, co-founder, who himself bravely fought brain cancer and started the Fund with his wife, Dellann, before passing in 2002. The goal of the organization is and has always been about providing IMMEDIATE ACCESS to advanced treatments, studies and clinical trials at the time of diagnosis vs. waiting to have this conversation after all Standard of Care treatments have failed. It has been about being Proactive rather than Reactive to brain cancer.

The primary reason behind our name change and new initiative is because industry, pharmaceutical companies, major donors and other partners have not fully understood that our direct one-on-one version of “Patient Support” has always been about fueling research through a Patient Focus and about getting these patients into advanced treatments quickly in order to create a greater quality of life, longer survivorship and perhaps, survivorship. As an organization, we had never properly defined our version of “Patient Support” and how our work leads to translational medicine and additional treatments quicker than the traditional method of filling clinical trials, therefore, our messaging and IMPACT had never properly been communicated. The EndBrainCancer Initiative is a bold attempt to create research partners and collaborative efforts in order to change our current Standard of Care to include discussions related to Consent Forms, education and enrollment into clinical trials at the point of diagnosis. Leadership and our Board of Directors adopted this change so that our primary emphasis and vision were clearer to the research and GBM community. As part of this process, we have developed:

Quite simply, our work and vision is to increase survivorship and to find a cure in our  lifetime through fueling research via our version of “Patient Support”.

Explore this site to discover related efforts included an expanded online Patient Support Resource area, the Connecting for Cure networking focus, and additional grassroots involvement options in our TAKE ACTION section.

We are excited for this change. With it we will advance our key priorities in 2015 and beyond.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram